Mycobacterium neoaurum and Mycobacterium bacteremicum sp. nov. as causes of mycobacteremia.
J. Clin. Microbiol., Dec;48(12):4377-85 (2010)
Five-year outbreak of community- and hospital-acquired Mycobacterium porcinum infections related to public water supplies.
J. Clin. Microbiol., Dec;49(12):4231-8 (2011)
Antimicrobial susceptibility of nontuberculous mycobacteria from eye infections.
Cornea., Aug;31(8):900-6 (2012)
Pulsed-field gel electrophoresis study of Mycobacterium abscessus isolates previously affected by DNA degradation.
J. Clin. Microbiol., Dec;42(12):5582-7 (2004)
Clinical and laboratory features of Mycobacterium porcinum.
J. Clin. Microbiol., Dec;42(12):5689-97 (2004)
Ethambutol ocular toxicity in treatment regimens for Mycobacterium avium complex lung disease.
Am. J. Respir. Crit. Care Med., Jul;172(2):250-3 (2005)
Polyphasic characterization reveals that the human pathogen Mycobacterium peregrinum type II belongs to the bovine pathogen species Mycobacterium senegalense.
J. Clin. Microbiol., Dec;43(12):5925-35 (2005)
Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy.
Clin. Microbiol. Rev., Apr;19(2):259-82 (2006)
Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease.
Am. J. Respir. Crit. Care Med., Oct;174(8):928-34 (2006)
Molecular analysis of Mycobacterium kansasii isolates from the United States.
J. Clin. Microbiol., Jan;42(1):119-25 (2004)
Thrice-weekly clarithromycin-containing regimen for treatment of Mycobacterium kansasii lung disease: results of a preliminary study.
Clin. Infect. Dis., Nov;37(9):1178-82 (2003)
Comparison of in vitro activities of gatifloxacin and ciprofloxacin against four taxa of rapidly growing mycobacteria.
Antimicrob. Agents Chemother., Oct;46(10):3283-5 (2002)
Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria.
Clin. Microbiol. Rev., Oct;15(4):716-46 (2002)
Diagnosis of nontuberculous mycobacterial infections.
Clin. Lab. Med., Dec;22(4):911-25, vi (2002)
Clinical and laboratory features of Mycobacterium mageritense.
J. Clin. Microbiol., Aug;40(8):2930-5 (2002)
Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria.
Antimicrob. Agents Chemother., Oct;46(10):3164-7 (2002)
Successful treatment of disseminated Mycobacterium chelonae infection with linezolid.
Clin. Infect. Dis., Oct;33(8):1433-4 (2001)
Mycobacterium immunogenum sp. nov., a novel species related to Mycobacterium abscessus and associated with clinical disease, pseudo-outbreaks and contaminated metalworking fluids: an international cooperative study on mycobacterial taxonomy.
Int. J. Syst. Evol. Microbiol., Sep;51(Pt 5):1751-64 (2001)
Evidence from molecular fingerprinting of limited spread of drug-resistant tuberculosis in Texas.
J. Clin. Microbiol., Oct;37(10):3255-9 (1999)
Mycobacterium wolinskyi sp. nov. and Mycobacterium goodii sp. nov., two new rapidly growing species related to Mycobacterium smegmatis and associated with human wound infections: a cooperative study from the International Working Group on Mycobacterial Ta
Int. J. Syst. Bacteriol., Oct;49 Pt 4:1493-511 (1999)
Early results (at 6 months) with intermittent clarithromycin-including regimens for lung disease due to Mycobacterium avium complex.
Clin. Infect. Dis., Feb;30(2):288-92 (2000)
Disseminated Nocardia pseudobrasiliensis infection in a patient with AIDS in Brazil.
Clin. Infect. Dis., Jan;28(1):144-5 (1999)
Clarithromycin-associated digoxin toxicity in the elderly.
Clin. Infect. Dis., Jan;24(1):92-3 (1997)
Relationship of adverse events to serum drug levels in patients receiving high-dose azithromycin for mycobacterial lung disease.
Clin. Infect. Dis., May;24(5):958-64 (1997)
Recognition of a Nocardia transvalensis complex by resistance to aminoglycosides, including amikacin, and PCR-restriction fragment length polymorphism analysis.
J. Clin. Microbiol., Sep;35(9):2235-42 (1997)
Randomly amplified polymorphic DNA PCR for comparison of Mycobacterium abscessus strains from nosocomial outbreaks.
J. Clin. Microbiol., Dec;35(12):3132-9 (1997)
Clinical application of PCR-restriction enzyme pattern analysis for rapid identification of aerobic actinomycete isolates.
J. Clin. Microbiol., Jan;36(1):148-52 (1998)
Initial (6-month) results of three-times-weekly azithromycin in treatment regimens for Mycobacterium avium complex lung disease in human immunodeficiency virus-negative patients.
J. Infect. Dis., Jul;178(1):121-6 (1998)
Results of operation in Mycobacterium avium-intracellulare lung disease.
Ann. Thorac. Surg., Aug;66(2):325-30 (1998)
DNA large restriction fragment patterns of sporadic and epidemic nosocomial strains of Mycobacterium chelonae and Mycobacterium abscessus.
J. Clin. Microbiol., Oct;31(10):2697-701 (1993)
Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease.
Am. J. Respir. Crit. Care Med., May;149(5):1335-41 (1994)
Rifampin-resistant Mycobacterium kansasii.
Clin. Infect. Dis., May;18(5):736-43 (1994)
Recent changes in taxonomy and disease manifestations of the rapidly growing mycobacteria.
Eur. J. Clin. Microbiol. Infect. Dis., Nov;13(11):953-60 (1994)
A case of recurrent typhoid fever in the United States: importance of the grandmother connection and the use of large restriction fragment pattern analysis of genomic DNA for strain comparison.
Pediatr. Infect. Dis. J., Dec;13(12):1103-6 (1994)
Reduced serum levels of clarithromycin in patients treated with multidrug regimens including rifampin or rifabutin for Mycobacterium avium-M. intracellulare infection.
J. Infect. Dis., Mar;171(3):747-50 (1995)
New Nocardia taxon among isolates of Nocardia brasiliensis associated with invasive disease.
J. Clin. Microbiol., Jun;33(6):1528-33 (1995)
Tuberculosis outbreak among healthcare workers in a community hospital.
Am. J. Respir. Crit. Care Med., Aug;152(2):808-11 (1995)
Adverse events associated with high-dose rifabutin in macrolide-containing regimens for the treatment of Mycobacterium avium complex lung disease.
Clin. Infect. Dis., Sep;21(3):594-8 (1995)
Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patients.
Am. J. Respir. Crit. Care Med., Jun;153(6 Pt 1):1766-72 (1996)
Azithromycin activity against Mycobacterium avium complex lung disease in patients who were not infected with human immunodeficiency virus.
Clin. Infect. Dis., Nov;23(5):983-9 (1996)
Varying dosages of rifabutin affect white blood cell and platelet counts in human immunodeficiency virus--negative patients who are receiving multidrug regimens for pulmonary Mycobacterium avium complex disease.
Clin. Infect. Dis., Dec;23(6):1321-2 (1996)
New developments in the treatment of nontuberculous mycobacterial (NTM) disease.
Semin Respir Infect., Dec;11(4):301-10 (1996)
Large restriction fragment patterns of genomic Mycobacterium fortuitum DNA as strain-specific markers and their use in epidemiologic investigation of four nosocomial outbreaks.
J. Clin. Microbiol., May;30(5):1250-5 (1992)
Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin.
J. Infect. Dis., Aug;166(2):405-12 (1992)
Large DNA restriction fragment polymorphism in the Mycobacterium avium-M. intracellulare complex: a potential epidemiologic tool.
J. Clin. Microbiol., Feb;31(2):390-4 (1993)
Drug intolerance to high-dose clarithromycin among elderly patients.
Diagn. Microbiol. Infect. Dis., 16(3):215-21 (1993)
Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae.
Ann. Intern. Med., Sep;119(6):482-6 (1993)
Sensitivity of fluorochrome microscopy for detection of Mycobacterium tuberculosis versus nontuberculous mycobacteria.
J. Clin. Microbiol., Apr;36(4):1046-9 (1998)
Heterogeneity among isolates of rapidly growing mycobacteria responsible for infections following augmentation mammaplasty despite case clustering in Texas and other southern coastal states.
J. Infect. Dis., Aug;160(2):281-8 (1989)
BRO beta-lactamases of Branhamella catarrhalis and Moraxella subgenus Moraxella, including evidence for chromosomal beta-lactamase transfer by conjugation in B. catarrhalis, M. nonliquefaciens, and M. lacunata.
Antimicrob. Agents Chemother., Nov;33(11):1845-54 (1989)
A descriptive study of 42 cases of Branhamella catarrhalis pneumonia.
Am. J. Med., May;88(5A):2S-8S (1990)
Chromosomal DNA fingerprint patterns produced with IS6110 as strain-specific markers for epidemiologic study of tuberculosis.
J. Clin. Microbiol., Sep;29(9):2030-3 (1991)
Antibiotic susceptibilities and drug resistance in Moraxella (Branhamella) catarrhalis.
Am. J. Med., May;88(5A):46S-50S (1990)
Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients.
Am. Rev. Respir. Dis., May;147(5):1271-8 (1993)
Susceptibility testing of Nocardia species for the clinical laboratory.
Diagn. Microbiol. Infect. Dis., Mar;9(3):155-66 (1988)
Clinical experience with linezolid for the treatment of nocardia infection.
Clin. Infect. Dis., Feb;36(3):313-8 (2003)
Mycobacterium simiae pseudo-outbreak resulting from a contaminated hospital water supply in Houston, Texas.
Clin. Infect. Dis., Oct;35(7):802-7 (2002)
Clostridium perfringens phospholipase C-induced platelet/leukocyte interactions impede neutrophil diapedesis.
J. Med. Microbiol., May;55(Pt 5):495-504 (2006)
Cytokine profiles in immunocompetent persons infected with Mycobacterium avium complex.
J. Infect. Dis., Feb;183(3):478-84 (2001)
Abscesses due to mycobacterium abscessus linked to injection of unapproved alternative medication.
Emerging Infect. Dis., 5(5):681-7 (1999)
Nosocomial outbreaks/pseudo-outbreaks caused by nontuberculous mycobacteria.
Annu. Rev. Microbiol., 52:453-90 (1998)
Catheter sepsis due to Mycobacterium chelonae.
J. Clin. Microbiol., Nov;36(11):3444-5 (1998)
Polyclonal Mycobacterium avium complex infections in patients with nodular bronchiectasis.
Am. J. Respir. Crit. Care Med., Oct;158(4):1235-44 (1998)
Long-term laboratory contamination by Mycobacterium abscessus resulting in two pseudo-outbreaks: recognition with use of random amplified polymorphic DNA (RAPD) polymerase chain reaction.
Clin. Infect. Dis., Jul;27(1):169-75 (1998)
Mycobacterium avium complex lung disease and women. Now an equal opportunity disease.
Chest., Jan;105(1):6-7 (1994)
Lack of rifabutin resistance with prophylaxis for disseminated Mycobacterium avium complex.
Lancet., Nov;344(8935):1506-7 (1994)
Chronic otitis media after tympanostomy tube placement caused by Mycobacterium abscessus: a new clinical entity?
Am J Otol., May;15(3):313-20 (1994)
Rapid development of resistance to clarithromycin following monotherapy for disseminated Mycobacterium chelonae infection in a heart transplant patient.
Clin. Infect. Dis., Feb;20(2):443-4 (1995)
Molecular mechanisms of clarithromycin resistance in Mycobacterium avium: observation of multiple 23S rDNA mutations in a clonal population.
J. Infect. Dis., Aug;174(2):354-60 (1996)
Report on an outbreak of postinjection abscesses due to Mycobacterium abscessus, including management with surgery and clarithromycin therapy and comparison of strains by random amplified polymorphic DNA polymerase chain reaction.
Clin. Infect. Dis., Jun;24(6):1147-53 (1997)
Central nervous system infections with nontuberculous mycobacteria.
Clin. Infect. Dis., Dec;25(6):1496-7 (1997)
AIDS-related Mycobacterium kansasii infection with initial resistance to clarithromycin.
Diagn. Microbiol. Infect. Dis., Jun;31(2):369-71 (1998)
Contamination of flexible fiberoptic bronchoscopes with Mycobacterium chelonae linked to an automated bronchoscope disinfection machine.
Am. Rev. Respir. Dis., Apr;145(4 Pt 1):853-5 (1992)
Isoelectric focusing of beta-lactamases from sputum and middle ear isolates of Branhamella catarrhalis recovered in the United States.
Drugs., 31 Suppl 3:48-54 (1986)
Branhamella catarrhalis as a lower respiratory tract pathogen in patients with chronic lung disease.
Arch. Intern. Med., May;146(5):890-3 (1986)
Disseminated Mycobacterium chelonae ssp. abscessus in an immunocompetent host and with a known portal of entry.
J. Am. Acad. Dermatol., May;20(5 Pt 2):909-12 (1989)
The clinical presentation, diagnosis, and therapy of cutaneous and pulmonary infections due to the rapidly growing mycobacteria, M. fortuitum and M. chelonae.
Clin. Chest Med., Sep;10(3):419-29 (1989)
Ofloxacin in community-acquired lower respiratory infections. A comparison with amoxicillin or erythromycin.
Am. J. Med., Dec;87(6C):52S-56S (1989)
Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy.
Antimicrob. Agents Chemother., Jan;34(1):65-70 (1990)
Diagnostic and therapeutic considerations for cutaneous Mycobacterium haemophilum infections.
Arch Dermatol., Feb;127(2):276-7 (1991)
Nosocomial outbreak of respiratory tract colonization with Mycobacterium fortuitum: demonstration of the usefulness of pulsed-field gel electrophoresis in an epidemiologic investigation.
Am. Rev. Respir. Dis., Nov;144(5):1153-9 (1991)
Tsukamurella paurometabolum: a novel pathogen causing catheter-related bacteremia in patients with cancer.
Clin. Infect. Dis., Jan;14(1):200-3 (1992)
Spectrum of disease due to rapidly growing mycobacteria.
Rev. Infect. Dis., 5(4):657-79 (1983)
Sternal wound infections and endocarditis due to organisms of the Mycobacterium fortuitum complex.
Ann. Intern. Med., Jun;98(6):938-9 (1983)